用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
$美鼎生物(VIVO)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001104659-22-101091 Act: 34 Size: 131 KB 网页链接
$美鼎生物(VIVO)$ DEFM14A Definitive proxy statement relating to merger or acquisition Accession Number: 0001193125-22-240989 Act: 34 Size: 1 MB 网页链接
$美鼎生物(VIVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000921895-22-002619 Act: 34 Size: 136 KB 网页链接
$美鼎生物(VIVO)$ PREM14A Preliminary proxy statements relating to merger or acquisition Accession Number: 0001193125-22-230084 Act: 34 Size: 1 MB 网页链接
$美鼎生物(VIVO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001102578-22-000093 Act: 34 Size: 10 KB 网页链接
$美鼎生物(VIVO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-22-213186 Act: 34 Size: 6 MB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-22-213166 Act: 34 Size: 336 KB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-22-205853 Act: 34 Size: 189 KB 网页链接
$美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-190481 Act: 34 Size: 22 KB 网页链接
$美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189141 Act: 34 Size: 659 KB 网页链接